| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |